Stocks & Investing
Fri, October 4, 2024
[ 12:00 AM ] - WOPRAI
Tue, October 1, 2024
[ 12:00 AM ] - WOPRAI
Mon, September 30, 2024
[ 12:00 AM ] - WOPRAI
Tue, September 24, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, September 17, 2024
[ 12:00 AM ] - WOPRAI
Mon, September 9, 2024
[ 12:00 AM ] - WOPRAI
Fri, August 30, 2024
[ 12:00 AM ] - WOPRAI
Mon, August 19, 2024
[ 12:00 AM ] - WOPRAI
Thu, August 15, 2024
[ 12:00 AM ] - WOPRAI
Tue, August 13, 2024
[ 12:00 AM ] - WOPRAI
Wed, August 7, 2024
[ 12:00 AM ] - WOPRAI
Mon, July 29, 2024
[ 12:00 AM ] - WOPRAI
Mon, July 22, 2024
[ 12:00 AM ] - WOPRAI
Wed, July 17, 2024
[ 12:00 AM ] - WOPRAI
Wed, February 28, 2024
[ 12:00 AM ] - WOPRAI
Thu, August 3, 2023
Fri, January 6, 2023
[ 12:00 AM ] - WOPRAI
Fri, November 11, 2022
Fri, September 16, 2022
Wed, January 12, 2022
Fri, April 16, 2021
Tue, March 6, 2018
Fri, November 10, 2017
Thu, August 17, 2017
[ 12:00 AM ] - WOPRAI
Thu, May 18, 2017
Fri, August 12, 2016 Jason Kolbert Maintained (TRVI) at Strong Buy and Held Target at $21 on, Oct 4th, 2024
Jason Kolbert of EF Hutton, Maintained "Trevi Therapeutics, Inc." (TRVI) at Strong Buy and Held Target at $21 on, Oct 4th, 2024.
Jason has made no other calls on TRVI in the last 4 months.
There are 4 other peers that have a rating on TRVI. Out of the 4 peers that are also analyzing TRVI, 0 agree with Jason's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Jason
- Faisal Khurshid of "Leerink Partners" Initiated at Buy and Held Target at $7 on, Monday, September 9th, 2024
- Oren Livnat of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $6 on, Friday, August 30th, 2024
- Ryan Deschner of "Raymond James" Initiated at Buy and Held Target at $9 on, Friday, August 30th, 2024
- Brandon Folkes of "Rodman & Renshaw" Initiated at Strong Buy and Held Target at $7 on, Thursday, June 13th, 2024
